In the UK, cancer rates in 25 to 49-year-olds increased by 22 per cent in the last three decades, the biggest change in any ...

A massive undertaking to map cancer tumours is providing new insights into how the disease forms, evolves and develops resistance to treatments ...

Patients with advanced bladder cancer that had spread to other parts of the body (metastasized) have responded well in a phase I clinical trial of an investigational drug, TYRA-300.

Researchers have shown for the first time that it is possible for a specially designed 'mini-protein' to deliver a radiation ...

Around 8% of patients with advanced metastatic bladder cancer survive for five years or more. In healthy, normal cells, Fibroblast ... can take the form of small changes, called mutations, or ...

“In this multicenter randomized clinical trial, we did not observe a benefit of prophylactic tranexamic acid in reducing red blood cell transfusion in patients undergoing open radical cystectomy for ...

Around 8% of patients with advanced metastatic bladder cancer survive for five years or more [2]. In healthy, normal cells ... can take the form of small changes, called mutations, or larger ...

Researchers have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a pivotal role in anti-tumor immunity. The pre-clinical findings highlight the potential to ...

ImmunityBio's Anktiva shows high complete response rates in trials, enhancing immunotherapy for BCG-unresponsive bladder cancer ... with advanced non-small cell lung cancer (NSCLC) treated ...

became one of only a small number of centres in England equipped to provide this complex treatment. For some of these patients, the treatment has cured them of their cancer. “CAR-T cell therapy is a ...